MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, PRLD made $6,500,000 in revenue. -$19,722,000 in net income. Net profit margin of -303.42%.

Income Overview

Revenue
$6,500,000
Net Income
-$19,722,000
Net Profit Margin
-303.42%
EPS
-$0.26
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenue
6,500,000 --1,333,333.333
Research and development
21,708,000 25,784,000 28,816,000 29,512,666.667
General and administrative
5,210,000 6,410,000 5,790,000 6,933,333.333
Total operating expenses
26,918,000 32,194,000 34,606,000 36,446,000
Loss from operations
-20,418,000 -32,194,000 -34,606,000 -35,112,666.667
Other income, net
693,000 963,000 2,521,000 3,478,666.667
Net loss
-19,725,000 -31,231,000 -32,085,000 -31,634,000
Unrealized gain (loss) on marketable securities, net of tax
3,000 -13,000 -23,000 -215,000
Comprehensive loss
-19,722,000 -31,244,000 -32,108,000 -31,849,000
Earnings per share, basic, total
-0.26 -0.41 -0.42 -0.417
Earnings per share, diluted, total
-0.26 -0.41 -0.42 -0.417
Weighted average number of shares outstanding, basic, total
76,132,337 75,993,941 75,986,281 -16,703
Weighted average number of shares outstanding, diluted, total
76,132,337 75,993,941 75,986,281 -16,703
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$19,722,000 Unrealized gain (loss) onmarketable securities, net...$3,000 Net loss-$19,725,000 Other income, net$693,000 Loss from operations-$20,418,000 Revenue$6,500,000 Total operatingexpenses$26,918,000 General andadministrative$5,210,000 Research and development$21,708,000

Prelude Therapeutics Inc (PRLD)

Prelude Therapeutics Inc (PRLD)